A Study in Healthy Japanese Men to Test How Well Different Doses of BI 1291583 Are Tolerated
Clinical trial NCT05183347 · COMPLETED
Trial details
- NCT number
- NCT05183347
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-04
- Primary completion
- 2022-07-27
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.